Randomized trial of 227 cancer survivors finds auricular point acupressure significantly reduces chemotherapy-induced peripheral neuropathy interference
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A three-arm randomized controlled trial of 227 cancer survivors with persistent chemotherapy-induced peripheral neuropathy found that a 4-week auricular point acupressure protocol significantly reduced neuropathy symptom severity at Week 1 and sustained significant reductions in neuropathy interference across all four weeks when delivered in person.
What NurseJet pulled from the source
Chemotherapy-induced peripheral neuropathy (CIPN) persists for months to years following neurotoxic antineoplastic therapy with minimal established non-pharmacological interventions. In a pragmatic three-arm randomized controlled clinical trial (ClinicalTrials.gov NCT04920097), 227 adult cancer survivors with established CIPN were randomized to receive 4 weeks of auricular point acupressure (APA) with in-person mobile app support (mAPA, n = 80), video-guided self-placement with app support (vAPA, n = 75), or standard usual oncology care (n = 72). Both APA cohorts utilized the same standardized protocol applying vaccaria seeds to designated ear acupoints with one coaching session; usual care participants received standard supportive management without study-delivered acupressure. The primary study endpoint was achieving at least a 20% reduction from baseline in an Individualized Composite Outcome (ICO) targeting each patient's highest-rated neuropathy symptom by anatomical location. Secondary endpoints evaluated neuropathy interference, functional status, and quality of life. At Week 1, both acupressure arms achieved significantly greater symptom reduction than usual care (mAPA odds ratio [OR]: 2.60, 95% CI: 1.27–5.33; vAPA OR: 3.22, 95% CI: 1.48–7.01; both p < 0.01). For the mAPA group, the symptom advantage persisted through Week 2 (OR: 2.49, p = 0.02). Notably, for neuropathy interference in daily activities, in-person mAPA significantly outperformed usual care every single week (OR range: 3.29–4.28, all p < 0.01), alongside significant exploratory improvements in anxiety, depression, and pain interference.
Why this matters for nurses
Oncology and outpatient infusion nurses frequently care for cancer survivors struggling with chronic numbness, tingling, neuropathic pain, and loss of manual dexterity after taxane, platin, or vinca alkaloid regimens. Validating that a 4-week nurse-teachable auricular acupressure protocol yields rapid relief and consistently lowers neuropathy interference gives clinicians an evidence-supported, non-opioid supportive care modality to help patients regain functional independence.
Bedside takeaway
An RCT of 227 cancer survivors found 4 weeks of in-person auricular point acupressure significantly cut neuropathy symptom severity and reduced daily life interference.
Key takeaways
- Randomized trial enrolled 227 cancer survivors with CIPN allocated to in-person mAPA (n = 80), virtual vAPA (n = 75), or usual care (n = 72).
- At Week 1, both acupressure arms significantly exceeded usual care in achieving >=20% reduction in their primary neuropathy symptom (p < 0.01).
- In-person seed placement (mAPA) maintained significant symptom improvement through Week 2 (OR: 2.49, p = 0.02).
- Neuropathy interference in daily living was significantly lower in the mAPA group across all four weeks of therapy (OR: 3.29–4.28, all p < 0.01).
- Exploratory analyses showed concurrent reductions in anxiety, depression, and pain interference with in-person acupressure.
Practice implications
- Routinely screen oncology patients receiving neurotoxic chemotherapy for early neuropathic sensory symptoms using validated neuropathy grading scales. For survivors experiencing persistent CIPN symptoms that interfere with buttoning, typing, or walking, discuss auricular acupressure as an adjunct to supportive care, emphasizing that initial in-person seed placement and point localization provide the greatest symptom relief. Ensure skin over the auricle is intact before seed application, instruct patients to press points 3 minutes three times daily, and discontinue seeds if local redness or irritation occurs.
Limitations & cautions
- Pragmatic trial lacked sham-acupressure blinding or attention control; differential study attrition occurred with higher dropout in the virtual arm (52% completion in vAPA vs. 96% in usual care); symptom severity advantage attenuated after Week 2; long-term durability beyond the 4-week active intervention was not established.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed)
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (PubMed). Auricular point acupressure for chemotherapy-induced peripheral neuropathy: a randomized controlled trial.
https://pubmed.ncbi.nlm.nih.gov/42961520/
Professional education only
